Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for TAK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2008. Start Trial.
Date Value
July 31, 2026 50.60%
June 30, 2026 50.60%
May 31, 2026 50.60%
April 30, 2026 50.60%
March 31, 2026 50.60%
February 28, 2026 50.60%
January 31, 2026 50.60%
December 31, 2025 50.60%
November 30, 2025 50.60%
October 31, 2025 50.60%
September 30, 2025 50.60%
August 31, 2025 50.60%
July 31, 2025 50.60%
June 30, 2025 50.60%
May 31, 2025 50.60%
April 30, 2025 50.60%
March 31, 2025 50.60%
February 28, 2025 55.14%
January 31, 2025 55.14%
December 31, 2024 55.14%
November 30, 2024 55.14%
October 31, 2024 55.14%
September 30, 2024 55.14%
August 31, 2024 55.14%
July 31, 2024 55.14%
Date Value
June 30, 2024 55.14%
May 31, 2024 55.14%
April 30, 2024 55.14%
March 31, 2024 55.14%
February 29, 2024 55.14%
January 31, 2024 55.14%
December 31, 2023 55.14%
November 30, 2023 55.14%
October 31, 2023 55.14%
September 30, 2023 55.14%
August 31, 2023 55.14%
July 31, 2023 55.14%
June 30, 2023 55.14%
May 31, 2023 55.14%
April 30, 2023 55.14%
March 31, 2023 55.14%
February 28, 2023 55.14%
January 31, 2023 55.14%
December 31, 2022 55.14%
November 30, 2022 55.14%
October 31, 2022 55.14%
September 30, 2022 55.14%
August 31, 2022 55.14%
July 31, 2022 55.14%
June 30, 2022 55.14%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Daiichi Sankyo Co., Ltd. 64.07%
Ono Pharmaceutical Co., Ltd. 69.70%
Astellas Pharma, Inc. 51.90%
Sanofi 33.67%
Eisai Co., Ltd. 95.02%